Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:


Patients with IBD find symptom relief in the Cannabis field

Cannabis (or marijuana) has been used in traditional medicine to treat intestinal inflammation. A survey by Ravikoff Allegretti et al. at a specialized IBD clinic shows that, in the USA, marijuana is used by a substantial number of patients with IBD to alleviate their symptoms.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Scheme of the endocannabinoid system.


  1. Alhouayek, M. & Muccioli, G. G. The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity. Trends Mol. Med. 18, 615–625 (2012).

    Article  CAS  Google Scholar 

  2. Ravikoff Allegretti, J., Courtwright, A., Lucci, M., Korzenik, J. R. & Levine, J. Marijuana use patterns among patients with inflammatory bowel disease. Inflamm. Bowel Dis. 19, 2809–2814 (2013).

    Article  Google Scholar 

  3. Lal, S. et al. Cannabis use amongst patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 23, 891–896 (2011).

    Article  Google Scholar 

  4. Lahat, A., Lang, A. & Ben-Horin, S. Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study. Digestion 85, 1–8 (2012).

    Article  Google Scholar 

  5. Naftali, T. et al. Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study. Clin. Gastroenterol. Hepatol. 11, 1276–1280.e1 (2013).

    Article  CAS  Google Scholar 

  6. Pertwee, R. G. Pharmacological actions of cannabinoids. Handb. Exp. Pharmacol. 168, 1–51 (2005).

    Article  CAS  Google Scholar 

  7. Schicho, R. & Storr, M. A potential role for GPR55 in gastrointestinal functions. Curr. Opin. Pharmacol. 12, 653–658 (2012).

    Article  CAS  Google Scholar 

  8. Di Sabatino, A. et al. The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease. Mucosal Immunol. 4, 574–583 (2011).

    Article  CAS  Google Scholar 

  9. Marquéz, L. et al. Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue. PLoS ONE 4, e6893 (2009).

    Article  Google Scholar 

  10. Higuchi, L. M. et al. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am. J. Gastroenterol. 107, 1399–1406 (2012).

    Article  Google Scholar 

Download references


R. Schicho is supported by grants from the Austrian Science Fund (FWF: P 22771 and P 25633). M. Storr is supported by the Deutsche Forschungsgemeinschaft.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Martin Storr.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schicho, R., Storr, M. Patients with IBD find symptom relief in the Cannabis field. Nat Rev Gastroenterol Hepatol 11, 142–143 (2014).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing